Smith Hayes Advisers’s Elevance Health ELV Stock Holding History

Smith Hayes Advisers’s Portfolio ELV Stock Details ELV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q1	$1.67M	Buy	12,021 +165	+1%	+$22K	0.34%	82
2015 Q4	$1.65M	Sell	11,856 -378	-3%	-$52.1K	0.35%	84
2015 Q3	$1.71M	Sell	12,234 -1,499	-11%	-$225K	0.37%	81
2015 Q2	$2.25M	Sell	13,733 -390	-3%	-$62.3K	0.45%	72
2015 Q1	$2.18M	Sell	14,123 -929	-6%	-$132K	0.43%	71
2014 Q4	$1.89M	Sell	15,052 -2,439	-14%	-$301K	0.39%	71
2014 Q3	$2.09M	Sell	17,491 -599	-3%	-$68.7K	0.49%	61
2014 Q2	$1.95M	Sell	18,090 -199	-1%	-$20.5K	0.46%	69
2014 Q1	$1.82M	Buy	+18,289	New	+$1.65M	0.45%	70

Other funds holding ELV

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $30.5B AUM 29.95% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return

Nordea Investment Management Stockholm, Sweden $107B AUM 24.58% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Smith Hayes Advisers's ELV Position: Q1 2016 in Review

Smith Hayes Advisers increased its Elevance Health (ELV) stake by 1.4% in Q1 2016, buying an estimated $22K and bringing the position to 12,021 shares worth $1.67M. The position accounts for 0.34% of the portfolio, ranked #82.

Smith Hayes Advisers first reported a position in ELV in Q1 2014 and has held it in 9 quarters since. The position peaked at $2.25M in Q2 2015. 770 funds tracked by Wall St. Rank hold ELV as of Q1 2016.

Smith Hayes Advisers held 12,021 shares of Elevance Health worth $1.67M as of Q1 2016.
Smith Hayes Advisers bought 165 Elevance Health shares in Q1 2016, an estimated $22K.
Elevance Health made up 0.34% of Smith Hayes Advisers's portfolio in Q1 2016, its #82 holding.
Smith Hayes Advisers first reported a position in Elevance Health in Q1 2014 and has held it in 9 quarters since.
Smith Hayes Advisers's Elevance Health position peaked at $2.25M in Q2 2015.
770 funds tracked by Wall St. Rank held Elevance Health as of Q1 2016.

Based on Smith Hayes Advisers's 13F filing for Q1 2016, filed 16 May 2016.